• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM60 介导的 TAB2 的 SUMOylation 抑制 MAPK/NF-κB 的激活和固有免疫反应。

The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response.

机构信息

Department of Rheumatology and Immunology, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu, 610041, China.

Department of Virology, College of Life Sciences, Department of Immunology, Medical Research Institute, Wuhan University, Wuhan, 430072, China.

出版信息

Cell Mol Immunol. 2021 Aug;18(8):1981-1994. doi: 10.1038/s41423-020-00564-w. Epub 2020 Nov 12.

DOI:10.1038/s41423-020-00564-w
PMID:33184450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8322076/
Abstract

Activation of the TAK1 signalosome is crucial for mediating the innate immune response to pathogen invasion and is regulated by multiple layers of posttranslational modifications, including ubiquitination, SUMOylation, and phosphorylation; however, the underlying molecular mechanism is not fully understood. In this study, TRIM60 negatively regulated the formation and activation of the TAK1 signalosome. Deficiency of TRIM60 in macrophages led to enhanced MAPK and NF-κB activation, accompanied by elevated levels of proinflammatory cytokines but not IFN-I. Immunoprecipitation-mass spectrometry assays identified TAB2 as the target of TRIM60 for SUMOylation rather than ubiquitination, resulting in impaired formation of the TRAF6/TAB2/TAK1 complex and downstream MAPK and NF-κB pathways. The SUMOylation sites of TAB2 mediated by TRIM60 were identified as K329 and K562; substitution of these lysines with arginines abolished the SUMOylation of TAB2. In vivo experiments showed that TRIM60-deficient mice showed an elevated immune response to LPS-induced septic shock and L. monocytogenes infection. Our data reveal that SUMOylation of TAB2 mediated by TRIM60 is a novel mechanism for regulating the innate immune response, potentially paving the way for a new strategy to control antibacterial immune responses.

摘要

TAK1 信号小体的激活对于介导病原体入侵的先天免疫反应至关重要,并且受到多种翻译后修饰的调控,包括泛素化、SUMO 化和磷酸化;然而,其潜在的分子机制尚不完全清楚。在这项研究中,TRIM60 负调控 TAK1 信号小体的形成和激活。巨噬细胞中 TRIM60 的缺失导致 MAPK 和 NF-κB 的激活增强,伴随着促炎细胞因子而非 IFN-I 的水平升高。免疫沉淀-质谱分析鉴定 TAB2 为 TRIM60 的 SUMO 化而不是泛素化的靶标,导致 TRAF6/TAB2/TAK1 复合物以及下游 MAPK 和 NF-κB 途径的形成受损。TRIM60 介导的 TAB2 的 SUMO 化位点被鉴定为 K329 和 K562;用精氨酸取代这些赖氨酸可使 TAB2 的 SUMO 化失活。体内实验表明,TRIM60 缺失的小鼠对 LPS 诱导的败血症休克和单核细胞增生李斯特菌感染的免疫反应增强。我们的数据表明,TRIM60 介导的 TAB2 的 SUMO 化是调节先天免疫反应的一种新机制,可能为控制抗菌免疫反应开辟了新的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/4b252e3d3749/41423_2020_564_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/085380e662aa/41423_2020_564_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/7c3ea171034c/41423_2020_564_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/a7fbfc36aeb0/41423_2020_564_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/4b252e3d3749/41423_2020_564_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/085380e662aa/41423_2020_564_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/7c3ea171034c/41423_2020_564_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/a7fbfc36aeb0/41423_2020_564_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/677b/8322076/4b252e3d3749/41423_2020_564_Fig6_HTML.jpg

相似文献

1
The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response.TRIM60 介导的 TAB2 的 SUMOylation 抑制 MAPK/NF-κB 的激活和固有免疫反应。
Cell Mol Immunol. 2021 Aug;18(8):1981-1994. doi: 10.1038/s41423-020-00564-w. Epub 2020 Nov 12.
2
Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.磷酸肌醇依赖性激酶-1通过中断Toll样受体4信号通路中TAK1-TAB2复合物的形成来抑制TRAF6泛素化。
Cell Signal. 2015 Dec;27(12):2524-33. doi: 10.1016/j.cellsig.2015.09.018. Epub 2015 Sep 30.
3
Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway Interaction With the TAK1-TAB2 Complex.乙型肝炎表面抗原抑制核因子-κB 通路的激活与 TAK1-TAB2 复合物的相互作用。
Front Immunol. 2021 Feb 25;12:618196. doi: 10.3389/fimmu.2021.618196. eCollection 2021.
4
TAK1-binding protein 2 (TAB2) and TAB3 are redundantly required for TLR-induced cytokine production in macrophages.TAK1 结合蛋白 2(TAB2)和 TAB3 在巨噬细胞中 TLR 诱导细胞因子产生过程中冗余发挥作用。
Int Immunol. 2024 Aug 13;36(9):439-450. doi: 10.1093/intimm/dxae020.
5
Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.核因子κB受体激活剂配体(RANKL)通过包含RANK、TAB2和TRAF6的信号复合物激活TAK1丝裂原活化蛋白激酶激酶激酶。
Mol Cell Biol. 2002 Feb;22(4):992-1000. doi: 10.1128/MCB.22.4.992-1000.2002.
6
TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.TAB2、TRAF6和TAK1参与由肿瘤坏死因子受体、埃达受体(Edar)及其衔接蛋白埃达相关死亡结构域蛋白(Edaradd)诱导的核因子κB(NF-κB)激活。
Hum Mol Genet. 2005 Dec 1;14(23):3751-7. doi: 10.1093/hmg/ddi405. Epub 2005 Oct 26.
7
Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1.转化生长因子-β激活激酶 1(TAK1)和凋亡信号调节激酶 1(ASK1)丝裂原活化蛋白激酶激酶激酶之间的相互抑制及其被 TAK1 结合蛋白 2(TAB2)抑制,TAB2 是 TAK1 的衔接蛋白。
J Biol Chem. 2012 Jan 27;287(5):3381-91. doi: 10.1074/jbc.M111.317875. Epub 2011 Dec 13.
8
TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling.TRAF6 和 TAK1 有助于 SAMHD1 介导的 NF-κB 信号转导的负调控。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01970-20.
9
HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein.人嗜T淋巴细胞病毒1型(HTLV-1)Tax蛋白介导的TAK1激活涉及TAB2衔接蛋白。
Biochem Biophys Res Commun. 2008 Jan 4;365(1):189-94. doi: 10.1016/j.bbrc.2007.10.172. Epub 2007 Nov 5.
10
Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3.在缺乏TAB2和TAB3的情况下,白细胞介素-1和依赖TRAF6的TAK1激活。
Biochem J. 2017 Jun 26;474(13):2235-2248. doi: 10.1042/BCJ20170288.

引用本文的文献

1
Dexmedetomidine suppresses microglial activation in postoperative cognitive dysfunction via the mmu-miRNA-125/TRAF6 signaling axis.右美托咪定通过mmu-miRNA-125/TRAF6信号轴抑制术后认知功能障碍中的小胶质细胞激活。
Open Med (Wars). 2025 Jul 23;20(1):20251236. doi: 10.1515/med-2025-1236. eCollection 2025.
2
TAB2 Promotes Immune Escape and Chemoresistance Through NF-κB Pathway Activation in Cervical Cancer.TAB2通过激活NF-κB通路促进宫颈癌的免疫逃逸和化疗耐药。
J Cell Mol Med. 2025 Mar;29(6):e70522. doi: 10.1111/jcmm.70522.
3
Immune regulation by the SUMO family.

本文引用的文献

1
MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis.miR-181a-5p 和 miR-181a-3p 协同抑制血管炎症和动脉粥样硬化。
Cell Death Dis. 2019 May 7;10(5):365. doi: 10.1038/s41419-019-1599-9.
2
TRIM proteins.TRIM 蛋白。
Curr Biol. 2019 Jan 21;29(2):R42-R44. doi: 10.1016/j.cub.2018.11.026.
3
SUMO-Mediated Regulation of Nuclear Functions and Signaling Processes.SUMO 介导的核功能和信号转导过程的调节。
小泛素样修饰物(SUMO)家族对免疫的调节
Nat Rev Immunol. 2025 Mar 19. doi: 10.1038/s41577-025-01155-4.
4
Role of TLRs as signaling cascades to combat infectious diseases: a review.Toll样受体作为对抗传染病的信号级联反应的作用:综述
Cell Mol Life Sci. 2025 Mar 19;82(1):122. doi: 10.1007/s00018-025-05631-x.
5
Regulation of the immune microenvironment by SUMO in diabetes mellitus.SUMO对糖尿病免疫微环境的调节作用
Front Immunol. 2025 Feb 26;16:1506500. doi: 10.3389/fimmu.2025.1506500. eCollection 2025.
6
The alternative polyadenylation regulator CFIm25 promotes macrophage differentiation and activates the NF-κB pathway.选择性聚腺苷酸化调节因子CFIm25促进巨噬细胞分化并激活核因子κB通路。
Cell Commun Signal. 2025 Feb 28;23(1):115. doi: 10.1186/s12964-025-02114-1.
7
Diagnostic and Therapeutic Implications of the SUMOylation Pathway in Acute Myeloid Leukemia.SUMO化途径在急性髓系白血病中的诊断和治疗意义
Cancers (Basel). 2025 Feb 13;17(4):631. doi: 10.3390/cancers17040631.
8
Evaluating and Gene Polymorphisms and Serum Protein Levels and Their Association with Age-Related Macular Degeneration and Its Treatment Efficiency.评估基因多态性与血清蛋白水平及其与年龄相关性黄斑变性及其治疗效果的关联。
Medicina (Kaunas). 2024 Dec 16;60(12):2072. doi: 10.3390/medicina60122072.
9
Associations of (rs867186), (rs237025), (rs13278372) Polymorphisms and , , Protein Levels with Clinical and Morphological Features of Pituitary Adenomas.(rs867186)、(rs237025)、(rs13278372)多态性以及 、 、 蛋白水平与垂体腺瘤临床和形态学特征的关联
Cancers (Basel). 2024 Jul 10;16(14):2509. doi: 10.3390/cancers16142509.
10
The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.SUMO化修饰在肿瘤微环境中的新作用及治疗意义。
Exp Hematol Oncol. 2023 Jul 6;12(1):58. doi: 10.1186/s40164-023-00420-3.
Mol Cell. 2018 Aug 2;71(3):409-418. doi: 10.1016/j.molcel.2018.07.027.
4
TRIM Proteins and Their Roles in Antiviral Host Defenses.TRIM 蛋白及其在抗病毒宿主防御中的作用。
Annu Rev Virol. 2018 Sep 29;5(1):385-405. doi: 10.1146/annurev-virology-092917-043323. Epub 2018 Jun 27.
5
TRIM38 regulates NF-κB activation through TAB2 degradation in osteoclast and osteoblast differentiation.TRIM38 通过 TAB2 降解调节破骨细胞和成骨细胞分化中的 NF-κB 激活。
Bone. 2018 Aug;113:17-28. doi: 10.1016/j.bone.2018.05.009. Epub 2018 May 16.
6
CRISPR/Cas9 genome editing in human hematopoietic stem cells.CRISPR/Cas9 基因组编辑在人类造血干细胞中的应用。
Nat Protoc. 2018 Feb;13(2):358-376. doi: 10.1038/nprot.2017.143. Epub 2018 Jan 25.
7
SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death.SUMO 触发的 NR4A1 泛素化控制巨噬细胞细胞死亡。
Cell Death Differ. 2017 Sep;24(9):1530-1539. doi: 10.1038/cdd.2017.29. Epub 2017 Jun 16.
8
Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3.在缺乏TAB2和TAB3的情况下,白细胞介素-1和依赖TRAF6的TAK1激活。
Biochem J. 2017 Jun 26;474(13):2235-2248. doi: 10.1042/BCJ20170288.
9
Homeostatic Immunity and the Microbiota.稳态免疫与微生物群
Immunity. 2017 Apr 18;46(4):562-576. doi: 10.1016/j.immuni.2017.04.008.
10
Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5.对RNA病毒的天然免疫由RIG-I和MDA5的时序性及可逆性SUMO化修饰调控。
J Exp Med. 2017 Apr 3;214(4):973-989. doi: 10.1084/jem.20161015. Epub 2017 Mar 1.